Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Total Liabilities 2010-2023 | SIGA

Siga Technologies total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Siga Technologies Annual Total Liabilities
(Millions of US $)
2023 $57
2022 $25
2021 $40
2020 $20
2019 $101
2018 $101
2017 $468
2016 $448
2015 $470
2014 $407
2013 $177
2012 $78
2011 $50
2010 $15
2009 $19
Siga Technologies Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $57
2023-09-30 $34
2023-06-30 $22
2023-03-31 $22
2022-12-31 $25
2022-09-30 $31
2022-06-30 $20
2022-03-31 $17
2021-12-31 $40
2021-09-30 $29
2021-06-30 $17
2021-03-31 $16
2020-12-31 $20
2020-09-30 $28
2020-06-30 $26
2020-03-31 $30
2019-12-31 $101
2019-09-30 $100
2019-06-30 $100
2019-03-31 $100
2018-12-31 $101
2018-09-30 $91
2018-06-30 $470
2018-03-31 $468
2017-12-31 $468
2017-09-30 $462
2017-06-30 $459
2017-03-31 $457
2016-12-31 $448
2016-09-30 $476
2016-06-30 $506
2016-03-31 $479
2015-12-31 $470
2015-09-30 $462
2015-06-30 $442
2015-03-31 $426
2014-12-31 $407
2014-09-30 $393
2014-06-30 $198
2014-03-31 $201
2013-12-31 $177
2013-09-30 $182
2013-06-30 $154
2013-03-31 $103
2012-12-31 $78
2012-09-30 $60
2012-06-30 $58
2012-03-31 $51
2011-12-31 $50
2011-09-30 $5
2011-06-30 $9
2011-03-31 $11
2010-12-31 $15
2010-09-30 $16
2010-06-30 $18
2010-03-31 $16
2009-12-31 $19
2009-09-30 $20
2009-06-30 $22
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.605B $0.140B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.491B 28.56
Chugai Pharmaceutical (CHGCY) Japan $53.791B 23.36
Takeda Pharmaceutical (TAK) Japan $41.617B 6.74
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.119B 24.26
Shionogi (SGIOY) Japan $14.091B 12.19
Neurocrine Biosciences (NBIX) United States $13.257B 55.05
Sandoz Group AG (SDZNY) Switzerland $13.249B 0.00
United Therapeutics (UTHR) United States $11.073B 11.86
Catalent (CTLT) United States $10.127B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.554B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.747B 6.84
Revolution Medicines (RVMD) United States $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.963B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.543B 0.00
Alpine Immune Sciences (ALPN) United States $4.225B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.063B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.791B 0.00
Indivior (INDV) United States $2.656B 12.35
Evotec AG (EVO) Germany $2.566B 0.00
Summit Therapeutics (SMMT) United States $2.505B 0.00
Corcept Therapeutics (CORT) United States $2.381B 24.21
Dyne Therapeutics (DYN) United States $2.139B 0.00
PTC Therapeutics (PTCT) United States $1.927B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.888B 19.51
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.790B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.753B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.676B 9.93
Avadel Pharmaceuticals (AVDL) Ireland $1.629B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.79
Ardelyx (ARDX) United States $1.524B 0.00
4D Molecular Therapeutics (FDMT) United States $1.294B 0.00
Pacira BioSciences (PCRX) United States $1.245B 12.39
Soleno Therapeutics (SLNO) United States $1.230B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.197B 11.25
Xencor (XNCR) United States $1.166B 0.00
Collegium Pharmaceutical (COLL) United States $1.159B 7.13
Ocular Therapeutix (OCUL) United States $1.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.944B 0.00
Cronos Group (CRON) Canada $0.924B 0.00
Cassava Sciences (SAVA) United States $0.920B 0.00
ARS Pharmaceuticals (SPRY) United States $0.874B 0.00
USANA Health Sciences (USNA) United States $0.828B 13.03
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Sage Therapeutics (SAGE) United States $0.756B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Savara (SVRA) United States $0.685B 0.00
ProKidney (PROK) United States $0.651B 0.00
Silence Therapeutics (SLN) United Kingdom $0.645B 0.00
Lyell Immunopharma (LYEL) United States $0.605B 0.00
Verve Therapeutics (VERV) United States $0.564B 0.00
OmniAb (OABI) United States $0.560B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.558B 0.00
Korro Bio (KRRO) United States $0.556B 0.00
Exscientia (EXAI) United Kingdom $0.522B 0.00
Altimmune (ALT) United States $0.499B 0.00
KalVista Pharmaceuticals (KALV) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.462B 0.00
Larimar Therapeutics (LRMR) United States $0.450B 0.00
Tourmaline Bio (TRML) United States $0.428B 0.00
Harrow (HROW) United States $0.418B 0.00
Heron Therapeutics (HRTX) United States $0.416B 0.00
Lexeo Therapeutics (LXEO) United States $0.404B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.390B 0.00
Bioventus (BVS) United States $0.372B 0.00
Organogenesis (ORGO) United States $0.368B 69.75
Nature's Sunshine Products (NATR) United States $0.354B 19.80
Esperion Therapeutics (ESPR) United States $0.349B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.318B 0.00
ESSA Pharma (EPIX) Canada $0.313B 0.00
Metagenomi (MGX) United States $0.309B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.296B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.281B 0.00
Adherex Technologies (FENC) United States $0.263B 0.00
Nanobiotix S.A (NBTX) France $0.254B 0.00
Telomir Pharmaceuticals (TELO) United States $0.251B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.246B 0.00
Avita Medical (RCEL) United States $0.241B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Prelude Therapeutics (PRLD) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.216B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.195B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Century Therapeutics (IPSC) United States $0.184B 0.00
MediWound (MDWD) Israel $0.166B 0.00
Karyopharm Therapeutics (KPTI) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Regulus Therapeutics (RGLS) United States $0.153B 0.00
VAXART, INC (VXRT) United States $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.58
CytoDyn (CYDY) United States $0.145B 0.00
Relmada Therapeutics (RLMD) United States $0.141B 0.00
Inotiv (NOTV) United States $0.140B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.86
Citius Pharmaceuticals (CTXR) United States $0.130B 0.00
FibroGen (FGEN) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
OptiNose (OPTN) United States $0.115B 0.00
ProPhase Labs (PRPH) United States $0.113B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Journey Medical (DERM) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.074B 6.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Mural Oncology (MURA) $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.80
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Viracta Therapeutics (VIRX) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Nutriband (NTRB) United States $0.033B 0.00
JanOne (JAN) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
DURECT (DRRX) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.023B 0.00
Indaptus Therapeutics (INDP) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.47
MEI Pharma (MEIP) United States $0.022B 1.11
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
Surrozen (SRZN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.55